Trial intelligence / Profile preview

ZuraPrep antimicrobial effectiveness for surgical skin preparation

NCT02831998Phase 3Completed

Sponsor
Zurex Pharma
Start
Jul 2016
Primary completion
Apr 2017
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of ChloraPrep in surgical site infection (SSI), sponsored by Zurex Pharma. Started Jul 2016; status: completed.

02

Drugs

ChloraPrep
03

Conditions

surgical site infection (SSI)

Beyond the preview

Go deeper on NCT02831998.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02831998.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call